PharmTechnology

Ambroviks®

Ambroxol
Syrup
Release form Syrup
Respiratory system
Direction Respiratory system
15mg/5ml, 30mg/5ml
Dosage 15mg/5ml 30mg/5ml
No prescription
Availability of a prescription No prescription
For customers:

What Ambroviks is and what it is used for
The active ingredient is Ambroxol which refers to the group of mucolytics.

Ambroviks is prescribed for thinning and loosening of phlegm in acute and chronic respiratory diseases accompanied by impaired production and evacuation of bronchial secretion (mucus).
Use of Ambroviks facilitates expectoration and relieves cough.
If the condition is not improved or if you feel worse after 4-5 days after beginning of the treatment, consult your doctor.

Are you a healthcare system specialist?

Are you a healthcare system specialist?